Diabetes complications

Anti‐ VEGF monotherapy versus anti‐ VEGF therapy combined with laser or intravitreal glucocorticoid therapy for diabetic macular edema: A Bayesian network meta‐analysis

Diabetes Obes MetabPublished Bayesian network meta-analysis of randomised controlled trials

Authors' conclusion

Anti-VEGF monotherapy and anti-VEGF therapy combined with laser or intravitreal glucocorticoid therapy exerted comparable effects. However, the ranking chart recommends anti-VEGF therapy combined with laser therapy. Meanwhile, anti-VEGF therapy combined with intravitreal glucocorticoid therapy did not demonstrate significant benefits.

Study context

Population
Patients with diabetic macular edema (DME) in RCTs (PubMed, Embase, Cochrane Library)21 RCTs, eyes
Participants
1,798 patients
Comparison
Anti-VEGF monotherapy vs anti-VEGF combined with laser or intravitreal glucocorticoid
Outcome
Mean change from baseline in best-corrected visual acuity (BCVA) and central macular thickness (CMT)
Follow-up
6 and 12 months
Methodological detailsfixed-effects model
  • Fixed-effects model

Pooled result

As reported in the abstract

Mean BCVA and CMT changes from baseline
  • Anti-VEGF monotherapy and anti-VEGF combined with laser or intravitreal glucocorticoid did not significantly change mean central macular thickness (CMT) and best-corrected visual acuity (BCVA)
  • MD with 95% CrI
  • Fixed-effects model

Further pooled results

Simulation-based ranking for mean BCVA change: anti-VEGF + laser likely most effective

Anti-VEGF + laser most effective at 6 months
70.7515%
Anti-VEGF + laser most effective at 12 months
70.9315%

Simulation-based ranking for mean CMT change: anti-VEGF + laser likely most effective

Anti-VEGF + laser most effective at 6 months
83.6350%
Anti-VEGF + laser most effective at 12 months
74.7730%

Original publication

Anti‐ VEGF monotherapy versus anti‐ VEGF therapy combined with laser or intravitreal glucocorticoid therapy for diabetic macular edema: A Bayesian network meta‐analysis. Diabetes Obes Metab. Published 20 February 2025. doi:10.1111/dom.16270

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.